Outcomes of Yttrium-90 Radioembolization for Unresectable Combined Biphenotypic Hepatocellular-Cholangiocarcinoma
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 31 (5) , 701-709
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution ExperienceJournal of the National Comprehensive Cancer Network, 2018
- Combined hepatocellular cholangiocarcinoma: Controversies to be addressedWorld Journal of Gastroenterology, 2016
- Biphenotypic Primary Liver Carcinomas: Assessing Outcomes of Hepatic Directed TherapyAnnals of Surgical Oncology, 2015
- Combined hepatocellular-cholangiocarcinoma: A population-level analysis of an uncommon primary liver tumorLiver Transplantation, 2014
- Long-Term Outcome of Liver Transplantation for Combined Hepatocellular Carcinoma and CholangiocarcinomaTransplantation Proceedings, 2013
- Combined Hepatocellular and Cholangiocarcinoma (Biphenotypic) Tumors: Imaging Features and Diagnostic Accuracy of Contrast-Enhanced CT and MRIAmerican Journal of Roentgenology, 2013
- Transplantation versus resection for patients with combined hepatocellular carcinoma–cholangiocarcinomaJournal of Surgical Oncology, 2013
- Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imagingInternational Journal Of Clinical Practice, 2007
- Combined hepatocellular and cholangiocarcinomaCancer, 2002
- Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical studyCancer, 1985